{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:59:12Z","timestamp":1791208752353,"version":"4.1.0"},"reference-count":44,"publisher":"SAGE Publications","issue":"4_suppl","license":[{"start":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Toxicol"],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:p>PEGylated oil is a terminology used to describe cosmetic ingredients that are the etherification and esterification products of glycerides and fatty acids with ethylene oxide. The Cosmetic Ingredient Review Expert Panel (Panel) considered the safety of PEGylated oils, which function primarily as surfactants in cosmetic products. The Panel reviewed relevant animal and human data provided in this safety assessment and concluded that the 130 chemically related PEGylated oils were safe as cosmetic ingredients in the present practices of use and concentration when formulated to be nonirritating.<\/jats:p>","DOI":"10.1177\/1091581814546337","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T00:13:13Z","timestamp":1409184793000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":15,"title":["Safety Assessment of PEGylated Oils as Used in Cosmetics"],"prefix":"10.1177","volume":"33","author":[{"given":"Christina L.","family":"Burnett","sequence":"first","affiliation":[{"name":"Cosmetic Ingredient Review Scientific Analyst\/Writer, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Heldreth","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Chemist, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma F.","family":"Bergfeld","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald V.","family":"Belsito","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Hill","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis D.","family":"Klaassen","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Liebler","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"James G.","family":"Marks","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Shank","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Slaga","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Snyder","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Alan","family":"Andersen","sequence":"additional","affiliation":[{"name":"Former Director, Cosmetic Ingredient Review, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"issue":"53","key":"e_1_3_2_2_2","first-page":"269","article-title":"Final report on the safety assessment of PEG-30, -35, -36, and -40 castor oil and PEG-30 and -40 hydrogenated castor oil","volume":"16","author":"Andersen FA","year":"1997","unstructured":"Andersen FA, ed. Final report on the safety assessment of PEG-30, -35, -36, and -40 castor oil and PEG-30 and -40 hydrogenated castor oil. Int J Toxicol. 1997;16(53):269\u2013306.","journal-title":"Int J Toxicol"},{"issue":"6","key":"e_1_3_2_3_2","first-page":"319","article-title":"Group selectivity of ethyoxylation of hydroxy acids","volume":"44","author":"O'Lenick AJ","year":"1993","unstructured":"O'Lenick AJ, Parkinson JK. Group selectivity of ethyoxylation of hydroxy acids. J Soc Cosmet Chem. 1993;44 (6):319\u2013328.","journal-title":"J Soc Cosmet Chem"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2011.08.032"},{"key":"e_1_3_2_5_2","unstructured":"Shree Vallabh Chemicals. Castor Oil Ethoxylate. http:\/\/www.shreechem.in\/castor_oil_ethoxylates.html. Accessed January 23 2012."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(74)90099-4"},{"issue":"7","key":"e_1_3_2_7_2","first-page":"17","article-title":"Final report on the safety assessment of PEG-2, -6, -8, -12, -20, -32, -40, -50, -100, and -150 stearates","volume":"2","author":"Elder RL","year":"1983","unstructured":"Elder RL, ed. Final report on the safety assessment of PEG-2, -6, -8, -12, -20, -32, -40, -50, -100, and -150 stearates. JACT. 1983;2 (7):17\u201334.","journal-title":"JACT"},{"key":"e_1_3_2_8_2","unstructured":"Food and Drug Administration. 1 4-Dioxane. Silver Spring MD: Food and Drug Administration; 2007. http:\/\/www.fda.gov\/cosmetics\/productandingredientsafety\/potentialcontaminants\/ucm101566.htm. August 17 2012."},{"key":"e_1_3_2_9_2","volume-title":"International Cosmetic Ingredient Dictionary and Handbook","author":"Gottschalck TE","year":"2010","unstructured":"Gottschalck TE, Bailey JE, eds. International Cosmetic Ingredient Dictionary and Handbook. 13th ed. Washington, DC: Personal Care Products Council; 2010.","edition":"13"},{"key":"e_1_3_2_10_2","volume-title":"Frequency of Use of Cosmetic Ingredients. FDA Database","author":"Food and Drug Administration (FDA)","year":"2012","unstructured":"Food and Drug Administration (FDA). Frequency of Use of Cosmetic Ingredients. FDA Database. Washington, DC: FDA; 2012."},{"key":"e_1_3_2_11_2","unstructured":"Personal Care Products Council. Concentration of Use by FDA product category: PEGylated Castor Oil Ingredients; 2012:8."},{"key":"e_1_3_2_12_2","unstructured":"Personal Care Products Council. Concentration of use by FDA Product Category PEGylated Oils April 2012 Survey; 2012:4."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2011.05.1038"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","unstructured":"Rothe H. Special aspects of cosmetic spray evaluation; 2011.","DOI":"10.1016\/j.toxlet.2011.05.1038"},{"key":"e_1_3_2_15_2","unstructured":"Bremmer HJ Prud'homme de Lodder LCH Engelen JGM. Cosmetics fact sheet: to assess the risks for the consumer; updated version for ConsExpo 4; 2006:1\u201377. Report No. RIVM 320104001\/2006."},{"issue":"11","key":"e_1_3_2_16_2","first-page":"24","article-title":"The influence of particle size","volume":"14","author":"Johnsen MA","year":"2004","unstructured":"Johnsen MA. The influence of particle size. Spray Technol Mark. 2004 14(11):24\u201327.","journal-title":"Spray Technol Mark"},{"key":"e_1_3_2_17_2","unstructured":"European Union. 1976 Council Directive 1976\/768\/EEC of 27 July 1976 on the Approximation of the Laws of the Member States Relating to Cosmetic Products as amended through Commission Directive 2008\/42\/EC; 2008. http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=CONSLEG:1976L0768:20080424:en:PDF. Accessed: 8 March 24 2010"},{"issue":"1","key":"e_1_3_2_18_2","first-page":"220","article-title":"Development of isotretinoin gel for the treatment of acne vulgaris","volume":"2","author":"Waghmare N","year":"2011","unstructured":"Waghmare N, Waghmare P, Wani S, Yerawar A. Development of isotretinoin gel for the treatment of acne vulgaris. Res J Pharm Biol Chem Sci. 2011;2 (1):220\u2013230.","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.04.008"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/21\/1\/015101"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-007-0746-9"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1081\/DDC-120005632"},{"issue":"1","key":"e_1_3_2_23_2","first-page":"1","article-title":"GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion","volume":"2","author":"D'Cruz OJ","year":"2001","unstructured":"D'Cruz OJ, Yiv SH, Uckum FM. GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion. AAPS Pharm Sci Tech. 2001;2 (1):1\u201310.","journal-title":"AAPS Pharm Sci Tech"},{"issue":"4","key":"e_1_3_2_24_2","first-page":"274","article-title":"Prepartion and evaluation of microemulsion of vinpocetine for transdermal delivery","volume":"59","author":"Hua L","year":"2004","unstructured":"Hua L, Weisan P, Jiayu L, Hongfei L. Prepartion and evaluation of microemulsion of vinpocetine for transdermal delivery. Pharmazie. 2004;59 (4):274\u2013278.","journal-title":"Pharmazie"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.08.004"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(93)90073-O"},{"issue":"1","key":"e_1_3_2_27_2","first-page":"38","article-title":"Elevated glycemia and local inflammation after injecting N-methyl-2-pyrrolidone (NMP) into the marginal ear vein of rabbits","volume":"40","author":"Moreau JP","year":"2001","unstructured":"Moreau JP, Vachon PJ, Huneau MC. Elevated glycemia and local inflammation after injecting N-methyl-2-pyrrolidone (NMP) into the marginal ear vein of rabbits. Contemp Top Lab Anim Sci. 2001;40 (1):38\u201340.","journal-title":"Contemp Top Lab Anim Sci"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.2131\/jts.18.SupplementIII_1"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1999.1078"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000139354"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050026"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199706150-00006"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.2131\/jts.19.2_89"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2010.07.015"},{"issue":"6","key":"e_1_3_2_35_2","first-page":"459","article-title":"Formulation of microemulsion gel systems for transdermal delivery of celecoxib: In vitro permeation, anti-inflammatory activity and skin irritation tests","volume":"4","author":"Soliman SM","year":"2010","unstructured":"Soliman SM, Malak NSA, El-Gazayerly ON, Rehim AAA. Formulation of microemulsion gel systems for transdermal delivery of celecoxib: In vitro permeation, anti-inflammatory activity and skin irritation tests. Drug Discov Ther. 2010;4 (6):459\u2013471.","journal-title":"Drug Discov Ther"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-009-9268-4"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000334233"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2006.00983.x"},{"issue":"4","key":"e_1_3_2_39_2","first-page":"777","article-title":"Immunological erythroblastopenia induced by HCO-60 as a solvent of enocitabine (BH-AC)","volume":"50","author":"Ninomiya H","year":"1987","unstructured":"Ninomiya H, Hanada T, Nakazawa M, . Immunological erythroblastopenia induced by HCO-60 as a solvent of enocitabine (BH-AC). Acta Haematol Jpn. 1987;50 (4):777\u2013783.","journal-title":"Acta Haematol Jpn"},{"issue":"3","key":"e_1_3_2_40_2","first-page":"31","article-title":"Final report on the safety assessment of Ricinus communis (castor) seed oil, hydrogenated castor oil, glyceryl ricinoleate, glyceryl ricinoleate SE, ricinoleic acid, potassium ricinoleate, sodium ricinoleate, zinc ricinoleate, cetyl ricinoleate, ethyl ricinoleate, glycol ricinoleate, isopropyl ricinoleate, methyl ricinoleate, and octyldodecyl ricinoleate","volume":"26","author":"Andersen FA","year":"2007","unstructured":"Andersen FA, ed. Final report on the safety assessment of Ricinus communis (castor) seed oil, hydrogenated castor oil, glyceryl ricinoleate, glyceryl ricinoleate SE, ricinoleic acid, potassium ricinoleate, sodium ricinoleate, zinc ricinoleate, cetyl ricinoleate, ethyl ricinoleate, glycol ricinoleate, isopropyl ricinoleate, methyl ricinoleate, and octyldodecyl ricinoleate. Int J Toxicol. 2007;26 (suppl 3):31\u201377.","journal-title":"Int J Toxicol"},{"key":"e_1_3_2_41_2","volume-title":"Plant-Derived Fatty Acid Oils as Used in Cosmetics","author":"Burnett CL","year":"2011","unstructured":"Burnett CL, Fiume MM, Bergfeld WF, . Plant-Derived Fatty Acid Oils as Used in Cosmetics. Washington, DC: Cosmetic Ingredient Review; 2011."},{"key":"e_1_3_2_42_2","volume-title":"Amended Safety Assessment of Triethylene Glycol and Polyethylene Glycols (PEGs)-4, -6, -7, -8, -9, -10, -12, -14, -16, -18, -20, -32, -33, -40, -45, -55, -60, -75, -80, -90, -100, -135, -150, -180, -200, -220, -240, -350, -400, -450, -500, -800, -2 M, -5 M, -7 M, -9 M, -14 M, -20 M, -23 M, -25 M, -45 M, -65 M, -90 M, -115 M, -160 M and -180 M and Any PEGs \u2265 4 as Used in Cosmetics","author":"Bergfeld WF","year":"2010","unstructured":"Bergfeld WF, Belsito DV, Hill RA, . Amended Safety Assessment of Triethylene Glycol and Polyethylene Glycols (PEGs)-4, -6, -7, -8, -9, -10, -12, -14, -16, -18, -20, -32, -33, -40, -45, -55, -60, -75, -80, -90, -100, -135, -150, -180, -200, -220, -240, -350, -400, -450, -500, -800, -2 M, -5 M, -7 M, -9 M, -14 M, -20 M, -23 M, -25 M, -45 M, -65 M, -90 M, -115 M, -160 M and -180 M and Any PEGs \u2265 4 as Used in Cosmetics. Washington, DC: Cosmetic Ingredient Review; 2010."},{"key":"e_1_3_2_43_2","volume-title":"Safety Assessment of Simmondsia Chinensis (Jojoba) Seed Oil, Simmondsia Chinensis (Jojoba) Seed Wax, Hydrogenated Jojoba Oil, Hydrolyzed Jojoba Esters, Isomerized Jojoba Oil, Jojoba Esters, Simmondsia Chinensis (Jojoba) Buter, Jojoba Alcohol, and Synthetic Jojoba Oil","author":"Becker LC","year":"2008","unstructured":"Becker LC, Bergfeld WF, Belsito DV, . Safety Assessment of Simmondsia Chinensis (Jojoba) Seed Oil, Simmondsia Chinensis (Jojoba) Seed Wax, Hydrogenated Jojoba Oil, Hydrolyzed Jojoba Esters, Isomerized Jojoba Oil, Jojoba Esters, Simmondsia Chinensis (Jojoba) Buter, Jojoba Alcohol, and Synthetic Jojoba Oil. Washington, DC: Cosmetic Ingredient Review; 2008."},{"issue":"3","key":"e_1_3_2_44_2","first-page":"57","article-title":"Final amended report on the safety assessment of mink oil","volume":"24","author":"Andersen FA","year":"2005","unstructured":"Andersen FA, ed. Final amended report on the safety assessment of mink oil. Int J Toxicol. 2005;24 (suppl 3):57\u201364.","journal-title":"Int J Toxicol"},{"key":"e_1_3_2_45_2","first-page":"1","volume-title":"Alkyl PEG Ethers as Used in Cosmetics","author":"Fiume MM","year":"2010","unstructured":"Fiume MM, Bergfeld WF, Belsito DV, . Alkyl PEG Ethers as Used in Cosmetics. Washington, DC: Cosmetic Ingredient Review; 2010:1\u201399."}],"container-title":["International Journal of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1091581814546337","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1091581814546337","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1091581814546337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:24:33Z","timestamp":1777458273000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1091581814546337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":44,"journal-issue":{"issue":"4_suppl","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.1177\/1091581814546337"],"URL":"https:\/\/doi.org\/10.1177\/1091581814546337","relation":{},"ISSN":["1091-5818","1092-874X"],"issn-type":[{"value":"1091-5818","type":"print"},{"value":"1092-874X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]}}}